View Older Stories View More Recent Stories

Aug 19, 2025 12:09PM Stifel on Viking Therapeutic (VKTX) Sell-Off: 'an over-reaction to the successful Ph.2 VENTURE-Oral (13-week) outcome'
Aug 19, 2025 12:06PM William Blair on Viking Therapeutic (VKTX) Sell-Off: 'extreme and unwarranted'
Aug 19, 2025 11:24AM BTIG Reiterates Buy Rating on Viking Therapeutic (VKTX), PT $125
Aug 19, 2025 09:51AM Truist Securities Reiterates Buy Rating on Viking Therapeutic (VKTX)
Aug 19, 2025 08:36AM Novo Nordisk, Eli Lilly rise after Viking obesity trial data
Aug 19, 2025 08:21AM JPMorgan on Viking Therapeutic (VKTX): 'we still think oral vk-2735 offers strong efficacy with a manageable tolerability profile'
Aug 19, 2025 07:50AM Mizuho: Viking (VKTX) Oral Obesity Program is 'Quite Discouraging'
Aug 18, 2025 06:33AM Piper Sandler on Viking Therapeutic (VKTX): 'Strong Odds of Re-Rating of Oral VK2735 Sales'
Aug 18, 2025 05:18AM Oppenheimer Reiterates Outperform Rating on Viking Therapeutic (VKTX)
Aug 8, 2025 05:38AM Viking Therapeutics (VKTX) call put ratio 5.3 calls to 1 put with a focus on November 45 calls
Jul 24, 2025 09:27AM Stifel Reiterates Buy Rating on Viking Therapeutic (VKTX)
Jul 24, 2025 08:47AM Cantor Fitzgerald Reiterates Overweight Rating on Viking Therapeutic (VKTX)
Jul 24, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Jul 23, 2025 04:07PM Viking Therapeutics (VKTX) Misses Q2 EPS by 13c
Jun 26, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Jun 25, 2025 02:13PM BTIG Reiterates Buy Rating on Viking Therapeutic (VKTX)
Jun 25, 2025 12:05PM Leerink Partners Reiterates Outperform Rating on Viking Therapeutic (VKTX)
Jun 25, 2025 10:13AM H.C. Wainwright on Viking Therapeutic (VKTX): 'We expect the Phase 3 program to continue building on this foundation'
Jun 25, 2025 09:45AM Morgan Stanley on Viking (VKTX): 'we view initiation of large Ph3 studies on schedule as an incremental positive'
Apr 29, 2025 06:34AM Cantor Fitzgerald Starts Viking Therapeutic (VKTX) at Overweight
Apr 24, 2025 07:06AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Apr 23, 2025 04:12PM Viking Therapeutics (VKTX) Misses Q1 EPS by 8c
Apr 22, 2025 04:19PM Viking Therapeutic (VKTX) PT Lowered to $100 at Oppenheimer
Apr 21, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Apr 8, 2025 05:09AM Goldman Sachs Starts Viking Therapeutic (VKTX) at Neutral
Mar 27, 2025 06:37AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Mar 26, 2025 09:45AM Truist Weighs In on Obesity: 'Catalyst-Rich 2025 Ahead in a Growing Competitive Landscape'
Mar 16, 2025 10:00AM Will Pfizer step into the obesity ring? Wolfe Research answers
Mar 11, 2025 07:03AM Viking Therapeutics (VKTX) Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735
Mar 11, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Feb 21, 2025 12:29PM Viking Therapeutics (VKTX) Strength Said to be Tied to Unconfirmed M&A Chatter
Feb 7, 2025 06:52AM Citi Starts Viking Therapeutic (VKTX) at Neutral
Feb 6, 2025 12:07PM Viking Therapeutic (VKTX) PT Lowered to $95 at Truist Securities
Feb 6, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Feb 5, 2025 04:13PM Viking Therapeutics (VKTX) Misses Q4 EPS by 4c
Feb 5, 2025 10:46AM Viking Therapeutics (VKTX) call put ratio 16 calls to 1 put with a focus on February 7 weekly calls into quarter results
Feb 4, 2025 10:21AM Viking Therapeutics (VKTX) ticks higher on industry chatter
Jan 23, 2025 05:17AM Viking Therapeutics (VKTX) call put ratio 6.3 calls to 1 put with a focus on January 24 weekly calls
Jan 21, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Jan 15, 2025 04:52AM Viking Therapeutics (VKTX) call put ratio 1.3 calls to 1 put as share price trends lower
Jan 9, 2025 10:28AM Truist Securities Reiterates Buy Rating on Viking Therapeutic (VKTX) 'As Competitor Data Disappoint'
Jan 8, 2025 07:03AM Viking Therapeutics (VKTX) Initiates Phase 2 VENTURE-Oral Dosing Trial of VK2735
Dec 20, 2024 07:13AM Viking Therapeutics (VKTX), Others Gain After Novo Nordisk (NVO) Data Falls Short of Expectations
Dec 18, 2024 03:21PM Viking Therapeutics (VKTX) call put ratio 2. Calls to 1 put with focus on February calls
Dec 18, 2024 07:51AM Viking Therapeutics (VKTX) weakness tied to Merck's (MRK) Deal for GLP-1 Receptor Agonist
Dec 2, 2024 04:10AM Piper Sandler Starts Viking Therapeutic (VKTX) at Overweight
Nov 26, 2024 01:17PM BTIG Reiterates Viking Therapeutic (VKTX) at Buy, 'continue to see sub-q VK2735 remaining highly competitive'
Nov 22, 2024 02:25AM B.Riley Starts Viking Therapeutic (VKTX) at Buy
Nov 19, 2024 05:04PM After-hours movers: Dolby Laboratories, Powell Industries, Keysight Technologies
Nov 19, 2024 04:03PM Viking Therapeutics (VKTX) Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting
View More Recent Stories View Older Stories